Literature DB >> 25081183

Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment.

R E J Roach1, S C Cannegieter, W M Lijfering.   

Abstract

Men have a higher risk of first and recurrent venous thrombosis than do women. However, the pathophysiology underlying this phenomenon is as yet unknown. In this review article, we assessed the prevalence and strength of genetic and acquired risk factors for venous thrombosis for men and women separately, because it is likely that either a difference in effect or distribution of a risk factor explains the risk difference between the sexes. We also summarized the sex-specific results of previous studies on the risk of first and recurrent venous thrombosis. Few explanations for the sex difference were found. The major factor, explaining about 20% difference in population-attributable fraction, was body height. No difference in prevalence or strength for other venous thrombosis risk factors was observed, such as plaster cast immobilization, hospitalization, surgery, trauma, malignancy, hyperhomocysteinemia, factor V Leiden, prothrombin G20210A, or blood group non-O. Alternative explanations for the sex difference are hypothesized in this review, including X- or Y-linked mutations or a mutation on a gene with a sex-specific effect. Future studies should focus on the sex-specific risk of venous thrombosis to unravel the pathophysiology and thereby improve sex-specific treatment and prevention strategies. Even so, male sex can be used as a tool through which individuals at increased risk of first or recurrent venous thrombosis may be identified.
© 2014 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  epidemiology; pulmonary embolism; risk factors; sex; venous thrombosis

Mesh:

Substances:

Year:  2014        PMID: 25081183     DOI: 10.1111/jth.12678

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  33 in total

1.  Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.

Authors:  Kristina Sundquist; Abrar Ahmad; Peter J Svensson; Bengt Zöller; Jan Sundquist; Ashfaque A Memon
Journal:  J Thromb Thrombolysis       Date:  2018-08       Impact factor: 2.300

2.  Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States.

Authors:  Fadar Oliver Otite; Smit Patel; Richa Sharma; Pushti Khandwala; Devashish Desai; Julius Gene Latorre; Emmanuel Oladele Akano; Nnabuchi Anikpezie; Saef Izzy; Amer M Malik; Dileep Yavagal; Priyank Khandelwal; Seemant Chaturvedi
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

Review 3.  Global coagulation assays in hypercoagulable states.

Authors:  Hui Yin Lim; Geoffrey Donnan; Harshal Nandurkar; Prahlad Ho
Journal:  J Thromb Thrombolysis       Date:  2022-01-08       Impact factor: 2.300

4.  In-hospital left ventricular thrombus following ST-elevation myocardial infarction.

Authors:  Aiham Albaeni; Khaled Chatila; Hind A Beydoun; May A Beydoun; Mohammad Morsy; Wissam I Khalife
Journal:  Int J Cardiol       Date:  2019-07-23       Impact factor: 4.164

5.  Sport and Venous Thromboembolism—Site, Accompanying Features, Symptoms, and Diagnosis.

Authors:  Thomas Hilberg; Pia Ransmann; Thorsten Hagedorn
Journal:  Dtsch Arztebl Int       Date:  2021-03-19       Impact factor: 5.594

6.  Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index.

Authors:  Yeo Jin Choi; Yong Won Choi; Jung-Woo Chae; Hwi-Yeol Yun; Sooyoung Shin
Journal:  Risk Manag Healthc Policy       Date:  2021-05-07

7.  CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.

Authors:  Piyushkumar R Kapopara; Nooshin S Safikhan; Jenny L Huang; Scott C Meixner; Kevin Gonzalez; Houra Loghmani; Wolfram Ruf; Alan E Mast; Victor Lei; Edward L G Pryzdial; Edward M Conway
Journal:  J Thromb Haemost       Date:  2021-05-07       Impact factor: 16.036

Review 8.  Trauma-induced coagulopathy.

Authors:  Ernest E Moore; Hunter B Moore; Lucy Z Kornblith; Matthew D Neal; Maureane Hoffman; Nicola J Mutch; Herbert Schöchl; Beverley J Hunt; Angela Sauaia
Journal:  Nat Rev Dis Primers       Date:  2021-04-29       Impact factor: 65.038

9.  The Natural History, Treatments, and Outcomes of Portal Vein Thrombosis in Patients With Inflammatory Bowel Disease.

Authors:  Leonard Naymagon; Douglas Tremblay; Nicole Zubizarreta; Erin Moshier; Steven Naymagon; John Mascarenhas; Thomas Schiano
Journal:  Inflamm Bowel Dis       Date:  2021-01-19       Impact factor: 5.325

10.  Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study.

Authors:  Yao Chen; Jianping Zhao; Zhanguo Zhang; Zeyang Ding; Yifa Chen; Xiaoping Chen; Wanguang Zhang
Journal:  J Hepatocell Carcinoma       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.